Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7299997

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
29,739,000,000 JPY
55,407,000,000 JPY
27,424,000,000 JPY
Ordinary profit (loss)
2,143,000,000 JPY
1,868,000,000 JPY
1,098,000,000 JPY
Profit (loss)
1,535,000,000 JPY
1,377,000,000 JPY
717,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
Net assets
37,899,000,000 JPY
36,661,000,000 JPY
35,875,000,000 JPY
Total assets
75,999,000,000 JPY
75,802,000,000 JPY
76,274,000,000 JPY
Dividend paid per share
40.00
70.00
35.00
Basic earnings (loss) per share
179.75
159.98
82.18
Diluted earnings per share
Equity-to-asset ratio
0.499 xbrli:pure
0.484 xbrli:pure
0.470 xbrli:pure
Net cash provided by (used in) operating activities
769,000,000 JPY
627,000,000 JPY
-341,000,000 JPY
Net cash provided by (used in) investing activities
-1,749,000,000 JPY
-3,536,000,000 JPY
-1,422,000,000 JPY
Net cash provided by (used in) financing activities
477,000,000 JPY
14,000,000 JPY
1,272,000,000 JPY
Cash and cash equivalents
4,617,000,000 JPY
5,120,000,000 JPY
7,522,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.